Skip to main content
Science / Explained
Reading What Actually MattersArticle 2 of 5

What Purity Percentages Actually Mean

A purity percentage is not a ranking. It is a result produced under a specific method, from a specific sample, under specific conditions. The number is only meaningful inside the full documentation picture.

What Purity Percentages Actually Mean
A purity percentage is not a ranking. It is a result produced under a specific method, from a specific sample, under specific conditions. The number is only meaningful inside the full documentation picture.

Purity is usually the number people notice first.

It is easy to understand why. A percentage feels simple. It gives the reader something concrete to hold onto. A higher number appears stronger. A lower number appears weaker. The number seems to offer a quick answer.

But purity is not that simple.

A purity percentage is not a complete description of quality. It is a result produced under a specific analytical method, using a specific sample, under specific testing conditions. It tells the reader something important, but not everything.

THE NUMBER

When a COA reports purity, it is usually describing how much of the detected sample corresponds to the intended compound under the method used. In peptide testing, purity and related impurities are important quality attributes because synthetic peptide production can generate closely related impurities, fragments, or byproducts that need to be separated, detected, and understood. (Polypeptide)

That is why purity matters.

But the number should not be read alone.

A purity result becomes meaningful when the reader also knows what method was used, whether identity was confirmed, whether the test is batch-specific, and whether the report provides enough context to interpret the result. Without that context, the number can create a false sense of clarity.

A high number can look reassuring.

But the real question is how that number was generated.

THE METHOD

Different analytical procedures can produce different kinds of information.

A method used to assess purity is not the same as a method used to confirm identity. A method used to detect one class of impurity may not tell the reader everything about every possible impurity. This is why method validation matters in regulated quality systems. ICH Q2(R2) explains that analytical procedure validation is meant to demonstrate that a procedure is fit for its intended purpose. (U.S. Food and Drug Administration)

That phrase matters: intended purpose.

It means a test must be understood according to what it is designed to measure. A purity number does not automatically answer questions outside the scope of that test. It should be read as one result inside a larger documentation picture.

WHY PURITY IS MISUNDERSTOOD

Purity is misunderstood because people want it to work like a ranking.

One number above another. One source better than another. One decision made simple.

But in peptides, purity is part of a larger quality conversation. The number may reflect synthesis quality, purification discipline, impurity control, analytical method, sample handling, and reporting structure. It is important, but it is not independent from everything that came before it.

This is why two purity numbers that look close may not be equally informative.

One may come with clear identity confirmation, batch traceability, method details, and a complete report. Another may appear as a single percentage without enough context to understand how it was produced.

The number may look similar.

The documentation may not be.

What this means

Purity should be read as a signal, not as the entire answer.

The better question is not only: what is the percentage?

The better question is: what does this percentage represent, how was it measured, and what other documentation supports it?

A purity number can be useful.

But only when it sits inside a clear structure of identity, method, batch connection, and traceability.

Catalyst reports purity inside that structure: identity, method, and batch alongside the number, not the number alone.

The better question is not what the percentage is. It is how that percentage was produced.

Previous
How to Read a COA Without a Science Background
Next
What Third-Party Testing Verifies, and What It Doesn't
Related articles

What Third-Party Testing Verifies, and What It Doesn't

Third-party testing is one of the strongest parts of a trust system when used correctly. It verifies what was tested, in the sample provided, using the method applied. It does not verify the entire supply chain.

What Third-Party Testing Verifies, and What It Doesn't

How to Read a COA Without a Science Background

A Certificate of Analysis is not a document written for experts. It is a structured record meant to connect a compound, a batch, a test method, and a result into one traceable story.

How to Read a COA Without a Science Background

Batch-Level Traceability Explained

Consistency is easy to claim. Batch-level traceability is how it is demonstrated. When documentation connects product, batch, and results into one path, the reader can follow it instead of assuming it.

Batch-Level Traceability Explained

Red Flags in Peptide Documentation

Not all documentation creates clarity. Recognizing patterns that add uncertainty rather than reduce it does not require a science background. It requires knowing which questions a document should answer.

Red Flags in Peptide Documentation
References6 sources
  1. United States Pharmacopeia (USP) · 2023
    Reference Standards to Support Quality of Synthetic Peptide Therapeutics.
    PMC / United States Pharmacopeia
  2. U.S. Food and Drug Administration · 2021
    ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin: Guidance for Industry.
    U.S. Food and Drug Administration
  3. ICH · 2000
    Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
    database.ich.org
  4. U.S. Food and Drug Administration · 2023
    Q2(R2) Validation of Analytical Procedures.
    U.S. Food and Drug Administration
  5. U.S. Food and Drug Administration · 2018
    Data Integrity and Compliance With Drug CGMP: Guidance for Industry.
    U.S. Food and Drug Administration
  6. PolyPeptide · 2014
    Control Strategies for Synthetic Therapeutic Peptide APIs, Part I: Analytical Consideration.
    Polypeptide